Advertisement
News
Advertisement

Epivax secures second NIH grant this year

Mon, 07/30/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Developer of therapeutics to treat cancer and autoimmune diseases Epivax Inc. has secured its second National Institutes of Health grant this year.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading